πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Pipeline programs

Browse 12,558 clinical pipeline programs from ClinicalTrials.gov, linked to pharma companies. Phase, modality, and trial IDs for BD teams.

12,558 programs 407 companies
project

3-dimensional conformal radiation therapy

UNITED THERAPEUTICS Corp

Phase 3 Β· other Β· active

1 trials
project

36-71 months old children-experimental EV71 vaccine.

SINOVAC BIOTECH LTD

Phase 3 Β· mab Β· completed

1 trials
project

4-aminopyridine

UNITED THERAPEUTICS Corp

Phase 3 Β· small_molecule Β· completed

1 trials
project

40 mg/day vormatrogine for 12 weeks

PRECISION BIOSCIENCES INC

Phase 3 Β· small_molecule Β· active

1 trials
project

400U /0.5ml EV71 vaccine

SINOVAC BIOTECH LTD

Phase 3 Β· mab Β· completed

1 trials
project

4D-150 IVT (3E10 vg/eye)

4D Molecular Therapeutics

Phase 3 Β· mab Β· active

1 trials
project

4D-150 IVT (3E10 vg/eye)

4D Molecular Therapeutics

Phase 3 Β· mab Β· active

1 trials
project

5 mg Serlopitant Tablets

VYNE Therapeutics

Phase 3 Β· small_molecule Β· terminated

3 trials
project

5 mg prednisone

Ultragenyx Pharmaceutical

Phase 3 Β· small_molecule Β· active

2 trials
project

5% Lidocaine patch

China SXT Pharmaceuticals

Phase 3 Β· small_molecule Β· completed

1 trials
project

5% cysteamine cream

China SXT Pharmaceuticals

Phase 3 Β· other Β· completed

1 trials
project

5% minoxidil foam

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

1 trials
project

5-Fu/epirubicin/CTX following Docetaxel

China SXT Pharmaceuticals

Phase 3 Β· small_molecule Β· active

1 trials
project

5mg Serlopitant Tablets

VYNE Therapeutics

Phase 3 Β· small_molecule Β· completed

2 trials
project

6-Thio-2'-Deoxyguanosine

MAIA Biotechnology

Phase 3 Β· small_molecule Β· active

2 trials
project

6-month course of antiandrogen drugs

First Tracks Biotherapeutics

Phase 3 Β· small_molecule Β· active

1 trials
project

60 mg ulixacaltamide

PRECISION BIOSCIENCES INC

Phase 3 Β· small_molecule Β· active

1 trials
project

600 mg Ibuprofen

UNITED THERAPEUTICS Corp

Phase 3 Β· small_molecule Β· active

1 trials
project

601 1.25mg

Sunshine Biopharma

Phase 3 Β· small_molecule Β· completed

2 trials
project

608

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

1 trials
project

608 Q2W

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

1 trials
project

608 Q2W

Sunshine Biopharma

Phase 3 Β· small_molecule Β· completed

1 trials
project

608 dose

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

1 trials
project

610

Sunshine Biopharma

Phase 3 Β· small_molecule Β· active

2 trials